| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 02/28/2008 | WO2008006883A3 Benzopyranopyrazoles |
| 02/28/2008 | US20080051582 Process for the preparation of tiotropium bromide |
| 02/28/2008 | US20080051580 Process to Prepare Camptothecin Derivatives and Novel Intermediate and Compounds Thereof |
| 02/28/2008 | US20080051425 Vinorelbine derivatives |
| 02/28/2008 | US20080051407 These compounds lack a 1,4-bridging group as found in the ecteinascidins; and, have at the C-1 position a substituent selected from an amino or hydroxy group, optionally protected or derivatized; anticarcinogenic agents |
| 02/28/2008 | CA2661503A1 Inhibitors of 11.beta. -hydroxysteroid dehydrogenase type 1 |
| 02/28/2008 | CA2660546A1 Aza-benzofuranyl compounds and methods of use |
| 02/28/2008 | CA2660084A1 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseases |
| 02/27/2008 | EP1892239A1 Inhibitors of cytosolic phospholipase A2 |
| 02/27/2008 | EP1891954A2 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder |
| 02/27/2008 | EP1891078A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 02/27/2008 | EP1891076A1 Substituted tetrahydroquinolines |
| 02/27/2008 | EP1891073A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
| 02/27/2008 | EP1891021A1 Aspartyl protease inhibitors |
| 02/27/2008 | EP1891013A1 Tetrahydroquinoline derivatives |
| 02/27/2008 | EP1562955B1 Quinazoline derivatives as src tyrosine kinase inhibitors |
| 02/27/2008 | EP1483266B1 Spiro compounds with npy antagonistic activity |
| 02/27/2008 | EP1395564B1 Quinoline derivatives as ligands for the neuropeptide y receptor |
| 02/27/2008 | EP1311300B1 Radioligand and binding assay |
| 02/27/2008 | CN101130546A Process for preparing irinotecan hydrochloride medicines |
| 02/27/2008 | CN101130545A Method for preparing ester compound and analogue of the same |
| 02/27/2008 | CN100371336C Pyrrole derivatives for treating diseases of cytokine mediated |
| 02/26/2008 | US7335667 Use as anticancer agents, immunosuppressants for transplants or autoimmune diseases, or against immune reactions (e.g. contact dermatitis or diarrhea) caused by other drugs; e.g. 3-(3-[methyl(1H-pyrrolo[2,3-b]pyridin-4-yl)amino]piperidin-1-yl)-3-oxopropanenitrile |
| 02/26/2008 | US7335666 That inhibit serotonin reuptake and are antagonists of the 5HT1A receptor; 2-[3-(6-Fluoro-indol-1-ylmethyl)-azetidin-1-ylmethyl]-8-methyl-2,3-dihydro-[1,4]dioxino[2,3-f]quinoline for example |
| 02/26/2008 | US7335665 Spirocyclic piperidines as MCH1 antagonists and uses thereof |
| 02/26/2008 | US7335662 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 4-(4-pyrimid-2-ylaminosulfonyl-1,4-phenylene-aminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole |
| 02/26/2008 | CA2225813C Antiparasitic marcfortines and paraherquamides |
| 02/21/2008 | WO2008020607A1 Phthalide derivative and salt thereof |
| 02/21/2008 | WO2008020270A1 Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate |
| 02/21/2008 | WO2008020222A1 Pyrrole derivatives with antibacterial activity |
| 02/21/2008 | WO2007149451A3 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 02/21/2008 | US20080045717 Methods Of Making Esters Of Camptothecins |
| 02/21/2008 | US20080045713 Tetrahydroisoquinolinedione derivative intermediates for the hemisynthesis of ecteinascidin or other tetrahydroisoquinolinephenol compounds |
| 02/21/2008 | US20080045538 Nitro and amino substituted topoisomerase agents |
| 02/21/2008 | US20080045526 Heteroaryl dihydroindolones as kinase inhibitors |
| 02/21/2008 | US20080045512 Benzoate salt of 4-(5-methyl-oxazolo[4,5-b]-pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane |
| 02/21/2008 | CA2660814A1 Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate |
| 02/21/2008 | CA2660318A1 Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activit y and use thereof |
| 02/21/2008 | CA2658720A1 Methods of making esters of camptothecins |
| 02/21/2008 | CA2633112A1 A method of treating tumors with azaxanthones |
| 02/20/2008 | EP1889840A1 Rearrangement of spirolactams |
| 02/20/2008 | EP1888592A1 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 02/20/2008 | EP1888585A1 Tetracyclic azapyrazinoindolines as 5-ht2 ligands |
| 02/20/2008 | EP1888550A2 Apoptosis promoters |
| 02/20/2008 | EP1888546A1 Thiazole derivatives and use thereof |
| 02/20/2008 | EP1888534A2 Organic compounds |
| 02/20/2008 | EP1888530A2 Quinoline derivatives as neurokinin receptor antagonists |
| 02/20/2008 | CN101128468A An efficient and stereoselective process for large scale synthesis of 3-(R)-3- (2,3-dihydrobenzofuran-5-yl)-1,2,3,4- tetrahydropyrrolo{3,4-B}quinolin-9-one |
| 02/20/2008 | CN101128467A New synthesis of a camptothecin subunit |
| 02/20/2008 | CN101128428A Novel pyridine derivatives as potassium ion channel openers |
| 02/20/2008 | CN101128197A Preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion |
| 02/20/2008 | CN101125856A Spiropyran compound with isocyanate trimer and its preparation method and application |
| 02/20/2008 | CN100369918C Preparation method of indole-containing heterocycle pyridinedihydrofuranketone |
| 02/20/2008 | CN100369917C Himbacine analogues as thrombin receptor antagonists |
| 02/20/2008 | CN100369916C 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 02/20/2008 | CN100369915C 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 02/19/2008 | US7332519 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene |
| 02/19/2008 | US7332512 Halogenated nitrobutadienes for controlling animal pests |
| 02/19/2008 | US7332492 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor |
| 02/19/2008 | US7332491 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease |
| 02/19/2008 | US7332487 Nitrogen-containing 5-membered ring compound |
| 02/19/2008 | CA2481723C 5ht2c receptor modulators |
| 02/14/2008 | WO2008017903A1 Positively charged water-soluble prodrugs of aryl- and heteroarylacetic acids with very fast skin penetration rate |
| 02/14/2008 | WO2008017688A1 2-carboxy thiophene derivatives as anti-viral agents |
| 02/14/2008 | WO2007117381A3 2 -aminopyridine analogs as glucokinase activators |
| 02/14/2008 | US20080039630 Cyanine compounds and their application as quenching compounds |
| 02/14/2008 | US20080039483 Novel Chelidonine Derivatives, Methods for the Production Thereof, and Use Thereof For Producing Pharmaceutical Agents |
| 02/14/2008 | US20080039456 4-[2-(4-nitro-phenyl)-6-oxo-4-thioxo-6H-1-oxa-3b,5-diaza-cyclopenta[a]pentalen-5-yl]-butyric acid, used for inhibiting heparin-binding proteins and in the treatment of pancreatic cancer; anticarcinogenic agents |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/13/2008 | EP1886999A2 Bicyclic heteroaromatic compound |
| 02/13/2008 | EP1885727A2 Syntheses and preparations of narwedine and related novel compounds |
| 02/13/2008 | EP1885726A2 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia |
| 02/13/2008 | EP1885713A1 1, 2, 4 -triazole derivatives as vasopressin antagonists |
| 02/13/2008 | EP1885359A1 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | CN101124229A Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 02/13/2008 | CN101121719A Method for preparing (S)-4-ethyl-6,6-disubstituted alkoxy(thio)-7,8-dihydro-4-hydroxy-1H-pyran[3,4-f]indoleridine-3,10-(4H)-dione compounds (I) |
| 02/13/2008 | CN101121718A Polysubstituted furanpyrimidine compounds and synthetic method thereof |
| 02/12/2008 | US7329687 Anticancer agents; antiproliferative agents |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/12/2008 | US7329673 selective agonists of (MC-4R); obesity, diabetes, male and female sexual dysfunction, insulin resistance, osteoartritis; long duration of action, side effects reduction; stereoisomers |
| 02/12/2008 | US7329668 For therapy of inflammatory diseases, immune diseases, and cancer |
| 02/12/2008 | CA2227695C Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 02/07/2008 | WO2008016989A1 Process for preparing pyranoindazole serotonergic receptor agonists |
| 02/07/2008 | WO2008016704A1 6-carboxy-normorphinan derivatives, synthesis and uses thereof |
| 02/07/2008 | WO2008016131A1 Fused heterocyclic compound |
| 02/07/2008 | WO2007149560A3 Fermentation and purification of actinomadura chromoprotein and related species |
| 02/07/2008 | WO2007109596A3 Heteroaryl dihydroindolones as kinase inhibitors |
| 02/07/2008 | US20080033183 Process for preparing pyranoindazole serotonergic receptor agonists |
| 02/07/2008 | US20080033177 Process for the preparation of substituted-1,2,3,4-tetrahydroisoquinoline derivatives |
| 02/07/2008 | CA2660027A1 6-carboxy-normorphinan derivatives, synthesis and uses thereof |
| 02/06/2008 | CN100366622C 20(S) camptotheca alkaloid derivatives, their preparing methods and uses |
| 02/06/2008 | CN100366621C Plumepoppy total alkaloid salt and its prepn and application |
| 02/05/2008 | US7326793 From a pyrrolidinone compound; coloring high molecular weight material |
| 02/05/2008 | US7326784 Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives |
| 02/05/2008 | US7326718 8-Substituted imidazopyridines |
| 02/05/2008 | US7326714 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 02/05/2008 | US7326713 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole |
| 02/05/2008 | US7326712 Substituted tricyclic compounds as protein kinase inhibitors |